USANA Health Sciences, Inc. USNA
NYSE
| 10/03/2026 | 07/04/2026 | 04/04/2026 | 01/03/2026 | 09/27/2025 | |
|---|---|---|---|---|---|
| Revenue | 905.58M | 913.36M | 925.94M | 925.26M | 912.67M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 905.58M | 913.36M | 925.94M | 925.26M | 912.67M |
| Cost of Revenue | 205.90M | 206.00M | 207.84M | 200.85M | 190.00M |
| Gross Profit | 699.68M | 707.36M | 718.09M | 724.41M | 722.67M |
| SG&A Expenses | 660.86M | 665.88M | 669.03M | 673.54M | 672.61M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 866.76M | 871.87M | 876.87M | 874.40M | 862.60M |
| Operating Income | 38.82M | 41.49M | 49.07M | 50.86M | 50.07M |
| Income Before Tax | -62.00K | 2.54M | 40.25M | 41.53M | 47.78M |
| Income Tax Expenses | 29.42M | 31.79M | 31.11M | 30.05M | 30.22M |
| Earnings from Continuing Operations | -29.48 | -29.25 | 9.15 | 11.48 | 17.56 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 8.28M | 7.09M | -273.00K | -717.00K | -567.00K |
| Net Income | -21.20M | -22.16M | 8.87M | 10.76M | 16.99M |
| EBIT | 38.82M | 41.49M | 49.07M | 50.86M | 50.07M |
| EBITDA | 71.44M | 73.92M | 81.57M | 83.42M | 78.07M |
| EPS Basic | -1.15 | -1.20 | 0.48 | 0.56 | 0.89 |
| Normalized Basic EPS | 1.89 | 1.92 | 1.81 | 1.81 | 1.83 |
| EPS Diluted | -1.15 | -1.21 | 0.47 | 0.55 | 0.88 |
| Normalized Diluted EPS | 1.89 | 1.92 | 1.81 | 1.81 | 1.82 |
| Average Basic Shares Outstanding | 73.68M | 73.48M | 73.51M | 74.16M | 74.96M |
| Average Diluted Shares Outstanding | 73.70M | 73.49M | 73.54M | 74.22M | 75.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |